U-SPECT 7 CT from MILabs (a Rigaku company) offers unmatched preclinical dynamic and whole body Single Photon Emission Computed Tomography (SPECT) performance, integrated with diagnostic micro-CT.
A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.
This eLearning module provides an up to date, evidence-based and comprehensive overview of practical guidelines for SPECT/CT imaging employed for both benign and malignant diseases.On the other hand, ...
Press releases are posted on Independent.com as a free community service. Santa Barbara, CA- Since 2020, the Cancer Foundation of Santa Barbara has invested more than $10M into the Nuclear Medicine ...
AIIMS Mangalagiri unveils advanced diagnostic imaging system and high-dose therapy ward for enhanced cancer treatment and ...